Immunization Update - PowerPoint PPT Presentation

Loading...

PPT – Immunization Update PowerPoint presentation | free to download - id: 3b8a86-MDY5M



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Immunization Update

Description:

Stanley E. Grogg, DO, FACOP Professor of Pediatrics Liaison Member of the Advisory Committee for Immunization Practices (ACIP) Have spoken for the following ... – PowerPoint PPT presentation

Number of Views:137
Avg rating:3.0/5.0
Slides: 54
Provided by: healthscie3
Category:

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Immunization Update


1
Immunization Update 2007
Stanley E. Grogg, DO, FACOP Professor of
Pediatrics Liaison Member of the Advisory
Committee for Immunization Practices (ACIP)
2
I have the following disclosures
  • Have spoken for the following pharmaceutical
    companies in the last 6 months
  • AstraZeneca
  • GlaxoSmithKline
  • Merck
  • MedImmune
  • Novartis
  • Primary Investigator in clinical vaccine
    research for the following companies
  • MedImmune
  • Merck
  • Sanofi-Pasture
  • GlaxoSmithKline
  • Wyeth

3
Objectivesand references
  • You will be able to list and recommend new
    vaccines available for public use
  • You will be able to employ the new vaccines into
    daily practice
  • http//www.vaccineinformation.org/photos
  • www.vaccineinformation.org
  • www.cdc.gov www.aap.org
  • www.nfid.org www.immunize.org

4
The Okie Good News
  • Improved from 44th in the nation in 2005 to 25th
    in 2006
  • OK Department of Health
  • 80.4 of OK children ages 19 months through 35
    months were immunized against 10 potentially
    deadly diseases (2006)

5
Available Vaccines
  • Pertussis
  • Pneumococcal
  • Polio Rabies
  • Rotavirus Rubella
  • Smallpox Tetanus
  • Typhoid
  • Yellow fever
  • More to come?
  • Anthrax BCG
  • Chickenpox Cholera
  • Diphtheria Hepatitis A
  • Hepatitis B Hib
  • HPV Influenza
  • Japanese encephalitis
  • Measles Mumps
  • Meningococcous

6
Which of the following patients should generally
NOT be given a live vaccine?
  • A. Pregnant women
  • B. Patients on chemotherapy
  • C. Patients currently on high corticosteroid
    doses for at least 14 days
  • D. All of the above

7
All of the following are live virus vaccines
EXCEPT
  • 1. FluMist
  • 2. RotaTeq
  • 3. Varivax and Zostavax
  • 4. MMR II
  • 5. IPV   

8
Advantages of Live Vaccines
  • Often protective after the first dose
  • Immunity is usually long-lasting 
  • A second dose is NOT really a booster but to
    stimulate immunity for those who did not react
    initially

9
In general avoid most live vaccines in patients
who are immunosuppressed
  • Avoid live vaccines until 3 months after stopping
    chemotherapy
  • Wait one month after high daily steroid doses
    (i.e. prednisone 20 mg, or 2 mg/kg) in patients
    taking them for at least 14 days
  • It's not necessary to avoid live vaccines while
    using inhaled steroids, steroid tapers or oral
    courses for less than 14 days
  • Antivirals can interfere with live vaccines
  • Wait 24 hours after stopping a herpes antiviral
    (i.e. acyclovir) to give Varivax and 2 weeks
    after giving FluMist to give an influenza
    antiviral if possible   

10
Avoid most live vaccines in patients who are
immuno-suppressed EXCEPTIONS
  • Household contacts
  • Can give MMR, Varivax, RotaTeq, and Zostavax to
    healthy people living with someone who is
    immunosuppressed
  • Pregnancy
  • Avoid live vaccines during pregnancy because of a
    theoretical risk of infection to the fetus
  • Use the inactivated flu vaccine during pregnancy
  • Timing of vaccinations
  • If LIVE INJECTABLE vaccines can't be given on the
    same day, give them at least 28 days apart

11
Religious exemptions for shots on the
rise Tulsa World, Oct. 20, 2007
  • All states have some requirement for
    immunizations
  • Allow parents to opt out for medical or religious
    reasons (Kansas, Missouri)
  • Allow parents to cite personal or philosophical
    reasons (Arkansas, Colorado, Oklahoma, Texas)
  • Allow only medical exemptions (Mississippi)

12
AAPs Vaccine Refusal Form
  • http//www.cispimmunize.org/
  • AAPs Childhood Immunization Support Program
  • If my child does not receive the vaccine(s), the
    consequences may include
  • -contracting the illness the vaccine should
    prevent
  • -transmitting the disease to others
  • -the need for my child to stay out of child care
    or school during disease outbreaks

13
True or False
  • Routine immunization is NO longer needed for
    polio, measles, mumps, varicella, pertussis,
    diphtheria, tetanus

14
2006 Outbreak prompts change to recommendations
on mumps
  • ACIP/AAP June 2006
  • Recommended routine MMR at 12-15 months ______
    AND specify that students attending colleges and
    other post-high school institutions receive _
    doses of MMR

15
Up Date VaricellaHow many doses are recommended?
  • August 2006
  • ACIP recommends 2nd dose of varicella
  • Children aged 4-6 years
  • Children, adolescents and adults who previously
    received only 1 dose
  • Outbreak situations

16
Rational for 2nd varicella dose
  • 20 of children who have received 1 dose are not
    fully protected
  • One dose may not provide protection into
    adulthood when infection with zoster virus is
    more severe

17
Recent Immunization Schedule Changes
  • HepB needs to be given at birth
  • Can be delayed only if health care provider order
    to withhold
  • Tdap adolescent
  • Hepatitis A
  • Meningococcal (MPSV4) conjugate vaccine

18
Recent Immunization Schedule Changes contd
  • Influenza vaccine for gt 6-59 months of age
  • Rotavirus (RotaTeq by Merck) for infants
  • HPV for adolescents

19
What disease is known as the 100 Day Cough?
  • RSV
  • Adenovirus
  • Rhinovirus
  • SARS
  • Pertussis

20
Tdap Recommendations
  • Use in place of Td as booster at 11 and 12 yrs
  • Use for 13-18 yr old who missed the 11 to 12 yrs
    dose of Td
  • 11-18 yrs of age who have already been vaccinated
    with Td are encouraged to receive a dose of Tdap
    to protect against pertussis if gt 2 years since
    booster
  • (www.cdc.gov/nip June 30, 2005)

21
Reasons for new Tdap recommendations
  • Pertussis still manages to cycle its way through
    communities
  • 2000-2005
  • 100 pertussis-related deaths US
  • 25,616 cases reported in 2005
  • Disease uncomfortable for anyone who has it
  • Cough for weeks

22
Tdap
  • Recommended in adults who are in close contact
    with infants younger than 12 months of age
  • Parents
  • Child care providers
  • HEALTH CARE PROVIDERS

23
Tdap for Pregnant Women
  • Tdap can be given instead of Td booster if
    increased risk of Pertussis or needs immediate
    protection (tetanus)
  • Source for Pertussis infection 15-20 of infants

24
So, Heath Care Providers?
  • Every time you see a newborn, you should ensure
    that the entire immediate family have all been
    immunized for pertussis

25
What should be given for wound prophylaxis for an
adolescent?
  • Ages 11-18

26
Question
  • Should a teen who has had pertussis be vaccinated
    with Tdap?

27
Question
  • What is the maximum age DTaP can be administered?
  • 3 years
  • 4 years
  • 5 years
  • 6 years
  • 7 years

28
For what age is the Hepatitis A now approved?
  • Can be given as young as
  • gt6 months of age
  • gt9 months of age
  • gt12 months of age
  • gt18 months of age
  • gt2 years of age

29
What would you recommend for an infant under one,
traveling to Mexico?
  • A. Risk prevention
  • Dont drink the water, etc.
  • B. Gamma globulin
  • C. Hep A to the adults in close contact with
    infant
  • D. All of the above
  • E. Only A and C above
  • Remember infants do not get significant clinical
    disease, thus discuss risk prevention and
    immunize those over 12 months traveling?

30
Cocoon Effect
  • Vaccinating one group to protect another
  • HepA in children to protect adults
  • Tdap in adolescents/adults to protect infants

31
ACIP New Recommendations for Hep A
  • Can be used as post-exposure prophylaxis rather
    than GG if given within 2 weeks of exposure
  • Can be given on the way to the airport if
    patient is traveling to high risk area

32
Twinrix by GSK Combination of A and B
  • For use 18 years of age and older
  • Saves 2 injections ?
  • Cannot be used as on the way to airport
    injection because the amount of A antigen is ½ of
    that in Havrix

33
Menactra (MCV4) (Sanofi) Indications (ACIP 2007)
  • Routine vaccination for all adolescent between
    11-18 years
  • College freshman living in dorms
  • Revaccination only if gt 5 years since Menomune
    (MPSV4) if student is at high risk
  • To be added to Vaccine Injury Compensation Program

34
Menactra (MCV4) (Sanofi) Indications (ACIP 2007)
  • Now approved and recommended down to 2 years of
    age for those at risk for meningococcal
    meningitis
  • ACIP recommends using Menactra rather than
    Menomune (MPSV4)
  • Conjugated vaccines stimulates both humoral and
    cellular responses

35
Guillain-Barre Syndrome (GBS) and Menactra
  • Vaccination still recommended
  • Not a greater than expected number of GBS events

36
Syncope and Menactra
  • Syncope is common among adolescents?
  • No specific relation to Menactra or any other
    vaccine

37
Menactra (MC4) (Sanofi)Vaccine
  • What N meningitidis serogroup is NOT in vaccine?
  • A
  • B
  • C
  • Y
  • W 135

38
Annual Influenza Vaccine
  • Recommended for 6-59 month-olds
  • In-home and out-of- home caregivers of children
    ages 2-5 years of age
  • And of course, all healthcare providers!

39
FluMist (LAIV) (MedImmune) Indications
  • 2-49 years, non-pregnant, healthy persons
  • Contraindicated in asthmatics
  • Do not use for workers in transplant units
  • NICU OK

40
New FluMist (2007-08 season)
  • 2-49 y/o (September 28, MMWR) healthy children
  • Reduction in volume of vaccine (.1) mL per
    nostril
  • Reduction in minimum dose spacing to 4 weeks for
    children who require 2 doses
  • Temperature requirements for storage 35-46
    degrees F

41
Flu Guidance (CDC)Partially Immunized lt 9 yrs of
age for 2007-08 season
  • Children 6 months-9 years should receive 2 doses
    separated by at least 1 month
  • NEW If the child lt 9 yrs received only one dose
    of influenza vaccine the first season they were
    immunized, they should receive 2 doses the
    following season

42
RotaTeq (Merck)Pentavalent live oral vaccine
  • ACIP recommendation
  • Infants should receive three doses of the oral
    vaccine at two, four, and six months of age to
    prevent moderate to severe Rotaviral infection
  • Children should receive the first dose of the
    vaccine by 12 weeks of age and should receive all
    doses of the vaccine by 32 weeks of age

43
Human Papillomavirus Virus Vaccination (HPV)
  • June 2006, ACIP recommendations
  • Be routinely given to girls at 11-12 year check
    up
  • Allows for vaccination of girls beginning at 9
    years of age
  • Vaccination of girls and women 13-26 years of age

44
Human Papillomavirus Virus Vaccination (HPV)
  • June 2006, ACIP recommendations
  • Vaccination is NOT recommended during pregnancy
  • Can be given to lactating women
  • Cervical cancer screening recommendations do not
    change

45
HPV the infection
  • Oncogenic (Protects against types 16 and 18)
  • Nononcogenic (Protects against types 6 and 11)

46
(No Transcript)
47
Pneumococcal Vaccines
  • Pneumovax-23
  • Pneumococcal polyvalent (23) polysaccharide
    vaccine
  • Cannot be given before 2 years of age
  • Protects against most common serotypes causing
    pneumonia in adults
  • Prevnar-7
  • Conjugate pneumococcal polyvalent (7) vaccine for
    infants and toddlers for protection of
    bacteremia, meningitis, pneumonia and some otitis
    media

48
Cost of New Vaccines
49
Who is Eligible to Receive VFC (age 18 or younger)
  • 1. Medicaid eligible
  • 2. Uninsured
  • 3. American Indian/Alaska Native
  • 4. Underinsured (has health insurance benefit
    plan that does NOT include vaccination
  • Only at Federally Qualified Health Center or
    Rural Health Clinic

50
Case a 11 y/o girl comes to your office in
October for a routine evaluation.
  • Her last set of immunizations was at age 5 years
    and she was up to date. Which of the following
    vaccinations would you recommend today?
  • Tdap
  • Menactra
  • Varivax
  • HPV
  • Influenza
  • Up date
  • HepB
  • MMR
  • HepA

51
The Future
  • New combinations
  • Avian (H5N1) vaccines by Sanofi is FDA approved,
    April 17, 2007
  • OSU-Clinical Vaccine Research
  • RSV/PIV-3 (MedImmune)
  • PCV-13 (includes 19A serotype) (Wyeth)
  • New MMRV (GSK)
  • Newer adjuvants (such as GSKs ASO4)
  • Personalized vaccine delivery system

52
Number one question by parents
  • What if I miss an appointment? Does my baby have
    to get the shots all over again?

53
Oklahomas Greatest
About PowerShow.com